TY - JOUR
T1 - Behavioral medicine for migraine and medication overuse headache
AU - Andrasik, Frank
AU - Buse, Dawn C.
AU - Grazzi, Licia
N1 - Funding Information:
Dr. Dawn C. Buse has served on the Advisory Board for Endo Pharmaceuticals and Allergan Pharmaceuticals, and has conducted research funded by grants to the National Headache Foundation from Allergan Pharmaceuticals, GlaxoSmithKline, Merck, Ortho-McNeil Neurologics Inc., and Endo Pharmaceuticals.
PY - 2009
Y1 - 2009
N2 - Primary headaches, including migraine and medication overuse headache (MOH), can be conceptualized as biobehavioral disorders based on the interaction of biological, psychological, and environmental factors. This article reviews empirically supported and efficacious behavioral approaches to the treatment and management of headaches in general, with an emphasis on migraine and MOH from a biopsychosocial perspective. Evidence-based behavioral medicine treatments for migraine and MOH are reviewed, including patient education, cognitive behavioral therapy, and biobehavioral training (biofeedback, relaxation training, and stress management). Information regarding psychological comorbidities and risk factors for progression of migraine and the development of MOH is also reviewed. Strategies are provided for enhancing adherence and motivation, as well as facilitating medical communication.
AB - Primary headaches, including migraine and medication overuse headache (MOH), can be conceptualized as biobehavioral disorders based on the interaction of biological, psychological, and environmental factors. This article reviews empirically supported and efficacious behavioral approaches to the treatment and management of headaches in general, with an emphasis on migraine and MOH from a biopsychosocial perspective. Evidence-based behavioral medicine treatments for migraine and MOH are reviewed, including patient education, cognitive behavioral therapy, and biobehavioral training (biofeedback, relaxation training, and stress management). Information regarding psychological comorbidities and risk factors for progression of migraine and the development of MOH is also reviewed. Strategies are provided for enhancing adherence and motivation, as well as facilitating medical communication.
UR - http://www.scopus.com/inward/record.url?scp=65649093019&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=65649093019&partnerID=8YFLogxK
U2 - 10.1007/s11916-009-0041-x
DO - 10.1007/s11916-009-0041-x
M3 - Review article
C2 - 19457287
AN - SCOPUS:65649093019
SN - 1531-3433
VL - 13
SP - 241
EP - 248
JO - Current pain and headache reports
JF - Current pain and headache reports
IS - 3
ER -